A phase 4 trial (NCT05181475) was initiated in December 2021 to examine the long-term efficacy and safety of GV-971 as well as changes in blood and gut microbiota biomarkers and thereby validate its mechanism of action and establish guidance for the more rational use of drugs in clinical practice
Mild side effects may include nausea, stomach upset, or headaches in some individuals
Instead of fighting your metabolism, we work with it regulating appetite, optimizing fat metabolism, and building a sustainable protocol around your health profile
This heightened demand for the drug also found its way into the black-market arena, often leading to serious adverse side effects, hospitalizations, and reactions resulting from exposure to contaminated products that bypassed the vetting for safety, quality, and efficacy of the product